PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Melperone→

Melperone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
3575-80-2
Molecular formula
C16H22FNO
Molecular weight
263.35 g/mol
Drug class
Butyrophenone antipsychoticdopamine and serotonin receptor antagonist
Mechanism of action
Has weak dopamine D2 receptor affinity relative to many conventional neuroleptics and modulates central dopaminergic, serotonergic and adrenergic signalling. Its atypical pharmacological profile is associated with antipsychotic and sedative effects with comparatively limited extrapyramidal effects in some studies.
Indications / reported uses
  • Treatment of psychotic disorders and selected behavioural disturbances in countries where melperone remains authorised; exact indication depends on local product information.

Sources: https://pubmed.ncbi.nlm.nih.gov/2573242/ · https://pubmed.ncbi.nlm.nih.gov/?term=melperone+clinical+antipsychotic · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Melperone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Melperone Permitted Daily Exposure (PDE) report (the Melperone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Melperone Occupational Exposure Limit (OEL) report (the Melperone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.